21.
Sebaceous carcinoma: evidence-based clinical practice guidelines
by Owen, Joshua L
The lancet oncology, 2019-12, Vol.20 (12), p.e699-e714

22.
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
by Ellis, Paul, Dr
The Lancet (British edition), 2009, Vol.373 (9676), p.1681-1692

23.
Influence of Algal Community Structure on Denitrification Rates in Periphyton Cultivated on Artificial Substrata
by Ishida, Cari K
Microbial ecology, 2008-07-01, Vol.56 (1), p.140-152

24.
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
by Labaj, Pawel P
Nature biotechnology, 2014-09, Vol.32 (9), p.903-914

25.
Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry
by Figeys, Daniel
Nature (London), 2002-01-10, Vol.415 (6868), p.180-183

26.
The Tuberculosis Drug Accelerator at year 10: what have we learned?
by Aldridge, Bree B
Nature medicine, 2021-08-01, Vol.27 (8), p.1333-1337

27.
Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trial
by Small, David S., PhD
Clinical therapeutics, 2010, Vol.32 (2), p.365-379

28.
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study
by Lessard, Christopher J
American journal of human genetics, 2012-04-06, Vol.90 (4), p.648-660

29.
Candida infective endocarditis
by Baddley, J. W
European journal of clinical microbiology & infectious diseases, 2008, Vol.27 (7), p.519-529

30.
Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype
by Kelly, Paul J
Journal of clinical pathology, 2010-02, Vol.63 (2), p.169-173

31.
Evidence for a Susceptibility Gene, SLEV1, on Chromosome 17p13 in Families with Vitiligo-Related Systemic Lupus Erythematosus
by Nath, Swapan K
American journal of human genetics, 2001, Vol.69 (6), p.1401-1406

32.
Development of associations between microalgae and denitrifying bacteria in streams of contrasting anthropogenic influence
by Peterson, Christopher G
FEMS microbiology ecology, 2011-09-01, Vol.77 (3), p.477-492

33.
Protein-Truncating Mutations in ASPM Cause Variable Reduction in Brain Size
by Bond, Jacquelyn
American journal of human genetics, 2003, Vol.73 (5), p.1170-1177

34.
Identification of a Systemic Lupus Erythematosus Susceptibility Locus at 11p13 between PDHX and CD44 in a Multiethnic Study
by Lessard, Christopher J
American journal of human genetics, 2011-01-07, Vol.88 (1), p.83-91

35.
Worsening Heart Failure During Hospitalization for Acute Heart Failure: Insights from ASCEND-HF
by Kelly, Jacob P Jacob P
The American heart journal, 2015-04-15, Vol.170 (2), p.298-305

36.
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
by van der Walt, Joelle M
American journal of human genetics, 2003-04, Vol.72 (4), p.804-811

37.
Functional profiling of the Saccharomyces cerevisiae genome
by Davis, Ronald W
Nature (London), 2002-07-25, Vol.418 (6896), p.387-391

38.
The Need to Quantify Ecosystem Services Provided By Birds
by Wenny, Daniel G
The Auk, 2011-01, Vol.128 (1), p.1-14

39.
Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents
by PATEL, Kunjal
AIDS (London), 2009, Vol.23 (14), p.1893-1901

40.
X-linked lymphoproliferative disease : twenty-five years after the discovery
by SEEMAYER, T. A
Pediatric research, 1995, Vol.38 (4), p.471-478
